Mesenchymal stem cells (MSCs) are multipotent cells able to differentiate along different pathways including chondrogenic, osteogenic and adipogenic lineages. MSCs with a fibroblast-like morphology have been identified in human fetal lung. However, their frequency and characterization in human adult lung have not been yet evaluated. Therefore, we analyzed the mesenchymal phenotype and differentiation ability of cultured human adult bronchial fibroblast-like cells (Br) in comparison with those of mesenchymal cell progenitors isolated from fetal lung (ICIG7) and adult bone marrow (BM212) tissues. Surface immunophenotyping by flow cytometry revealed a similar expression pattern of antigens characteristic of marrow-derived MSCs, including CD34 (À), CD45 (À), CD90/Thy-1 ( þ ), CD73/SH3, SH4 ( þ ), CD105/SH2 ( þ ) and CD166/ALCAM ( þ ) in Br, ICIG7 and BM212 cells. There was one exception, STRO-1 antigen, which was only weakly expressed in Br cells. Analysis of cytoskeleton and matrix composition by immunostaining showed that lung and marrow-derived cells homogeneously expressed vimentin and nestin proteins in intermediate filaments while they were all devoid of epithelial cytokeratins. Additionally, a-smooth muscle actin was also present in microfilaments of a low number of cells. All cell types predominantly produced collagen and fibronectin extracellular matrix as evidenced by staining with the monoclonal antibodies to collagen prolyl 4-hydroxylase and fibronectin isoforms containing the extradomain (ED)-A together with ED-B in ICIG7 cells. Br cells similarly to fetal lung and marrow fibroblasts were able to differentiate along the three adipogenic, osteogenic and chondrogenic mesenchymal pathways when cultured under appropriate inducible conditions. Altogether, these data indicate that MSCs are present in human adult lung. They may be actively involved in lung tissue repair under physiological and pathological circumstances. Laboratory Investigation (2005) 85, 962-971.
It is now well accepted that mesenchymal stem cells (MSCs) can be isolated from some human tissues, including adult bone marrow, peripheral blood, adipose tissue, articular synovium, amniotic fluid and other fetal tissues. [1] [2] [3] [4] [5] [6] [7] These MSCs share common characteristics including adherence to culture plastic, fibroblastic-like morphology and long-term proliferation ex vivo. They are generally defined as devoid of hematopoietic and endothelial markers (CD11c, CD31 and CD45) and express at variable extent several other surface antigens including CD90 (Thy-1), SH2 (CD105 or endoglin), SH3 or SH4 (CD73) and STRO-1. 1, 8 However, the most reliable biological criterion used to define MSCs remains their capacity to generate the three types of mesenchymal-derived tissue the bone, cartilage and fat tissue. 9 The ease of culture expansion and genetic manipulation of MSCs appears as one promising therapeutical approach to repair and correct diseased tissues of mesenchymal origin. Many experimental studies focus on the systemic and sitedirected administration of bone marrow-derived MSCs. The identification of resident MSCs in other adult tissues remains limited. For instance, the presence of MSCs in adult lung has not been yet documented even though lung MSCs might be logically more efficient therapeutically than the genetically modified bone marrow-derived MSCs currently under investigation for the treatment of lung diseases. [10] [11] [12] In the present study, we analyzed the mesenchymal phenotype and differentiation properties of fibroblast-like cells isolated from normal bronchial (Br) tissue in comparison with fetal lung and adult bone marrow-derived MSC progenitors. We show that Br fibroblast-like cells display in vitro a phenotype and multi-differentiation potentialities similar to those of the expanded MSC progeny from fetal lung and adult bone marrow tissue.
Materials and methods

Bronchial Biopsy Samples
Bronchial biopsies (n ¼ 3) were obtained from surgical specimens from smoker patients undergoing lobectomy for primary lung tumors. Tissues were removed distally to the tumor and found to be histologically free of neoplastic involvement, and to display a normal diploid karyotype. All biopsies were taken after the patients had given their informed consent.
Cell Culture
Br cells were isolated by enzymatic digestion as described previously for nasal tissue. 13 Briefly, after trimming off the bronchi from lung parenchyma and peribronchial vascular structures, tissues were digested for 2 h at 371C using collagenase (500 U/ml), hyaluronidase (30 U/ml) and DNAse (10 U/ml) from Sigma, St Quentin-Fallavier, France, in Dulbecco'smodified Eagle medium (DMEM; GIBCO-BRL, Cergy-Pontoise, France). Cells were then collected by centrifugation, washed twice and resuspended in high-glucose medium supplemented with 10% fetal calf serum (FCS, Gibco). All cells were plated in T25cm 2 culture flasks (ATGC Biotechnologie, Noisyle-Grand, France) in growth medium with a medium change twice a week until cells reach confluency. To maintain MSC differentiating potentialities, cells were serially subcultured at low cell density (approximately 10 cells/cm 2 ). Human fetal lung fibroblasts ICIG7, were generously provided by Dr Azzarone, Villejuif, France and isolated from a human second-trimester fetus as described.
14 Human bone marrow fibroblasts BM212, were isolated from a patient undergoing hip replacement surgery as previously described. 15 Analyses were performed at different passage (p) levels (from p4 to p10 for Br and BM212 cells and from p15 to p20 for ICIG7 cells). MAbs used against cytoskeletal and extracellular matrix elements were as follows: anti-human vimentin, anti-human pan-cytokeratin (CK) and anti-human a-smooth muscle actin (ASMA) from Sigma-Aldrich, St Quentin-Fallavier, France; antihuman prolyl 4-hydroxylase (clone 5B5) from DAKO, Trappes, France; anti-human nestin from R&D Systems, Lille, France; anti-human extradomain (ED)-A fibronectin (clone IST-9) and ED-B fibronectin (clone BC-1), a gift from Dr L Zardi, I.S.T., Genoa, Italy. Cells were seeded onto eightchamber Permanox Lab-Tek (Nalg Nunc, ATGC Biotechnologie, Marne-Lavallée, France), fixed with methanol for 5 min at À201C, and processed as previously described. 17 Fluorescent staining was observed on a DMR/HCS fluorescence microscope (Leica, Reuil-Malmaison, France) and images were acquired using Leica Lida software. The percentage of positive cells was determined on a total of 100 cells distributed in four different fields.
Cell Immunophenotyping
Adipogenic, Chondrogenic and Osteogenic Differentiation Assays
The potential of Br cells to differentiate into adipogenic, osteogenic and chondrogenic lineages was assayed at different passage levels. Cells were seeded in culture plates at 2.5 Â 10 4 cells/cm 2 in standard growth medium until confluence. Cells were then stimulated under appropriate inducible conditions. Unstimulated cells and cells treated with identical amounts of diluents were used as controls.
For adipogenic differentiation, 7 cells were stimulated with growth medium supplemented with 10 À6 M dexamethasone, 100 mg/ml 3-isobutyl-1-methylxanthine, 50 mM indomethacin and 10 mg/ml insulin (all from Sigma-Aldrich) for 3 weeks with a medium change twice a week. Cells were then rinsed twice with phosphate-buffered saline (PBS), fixed with 10% formalin for 10 min, washed with distilled water, rinsed in 60% isopropanol and covered with a 0.3% oil red O solution (SigmaAldrich) in 60% isopropanol. After 10 min, cultures were briefly rinsed in 60% isopropanol and thoroughly in distilled water and let dried at room temperature.
For chondrogenic differentiation, a modified technique described by Muraglia et al was used. 17 Briefly, cells were stimulated in growth medium supplemented with 1 ng/ml recombinant human transforming growth factor-beta1 (TGF-b1) from R&D systems, for 6 days. Cells were then rinsed twice with PBS, fixed with 10% formalin for 10 min at room temperature and washed with distilled water. For immunohistochemical analysis, cells were rehydrated in PBS and incubated in 5% hydrogen peroxide for 10 min. Nonspecific antibody binding was blocked by incubation with FCS diluted 1:20 in PBS containing 0.2% Triton X-100 (Sigma-Aldrich) for 30 min. Cells were then incubated with mouse anti-human type II collagen MAb (Chemicon International, Inc., Euromedex, Souffelweyersheim, France) diluted 1:5 in 0.5% FCS in PBS for 30 min. Slides were further incubated with biotinylated goat anti-mouse IgGs (Beckman Coulter) diluted 1:1000 in 0.5% FCS in PBS for 30 min. The antibody-biotin conjugates were detected with streptavidin-biotin-horseradish peroxidase complex (Beckman Coulter) applied for 30 min using diaminobenzidine (Sigma) as substrate. All incubations were carried out at room temperature. Nuclei were counterstained with hematoxylin. Negative controls were unstimulated and TGF-b1-treated cells incubated with normal mouse IgGs instead of the primary antibody.
For osteogenic differentiation, 3 cells were stimulated every 3-4 days in growth medium supplemented with 10 À7 M dexamethasone, 10 mM bglycerophosphate disodium and 50 mg/ml ascorbic acid (all from Sigma). After 4 weeks, cells were rinsed twice with PBS, fixed with formalin for 10 min, and washed with distilled water. To stain calcium deposits, cells were covered with a 2% aqueous solution of alizarin red S (Sigma), pH 4.2, for 3 min. Cultures were then washed thoroughly with distilled water and let dried at room temperature.
Gene Expression
Reverse-transcriptase polymerase chain reaction (RT-PCR) was used to determine the expression of peroximose proliferator-activated receptor g2 (PPARg2), osteopontin, type II collagen, and Sox-9, in cultures stimulated towards differentiation. Target genes were amplified by PCR with the following primers: human PPARg2, 
Results
Immunophenotype of Human Adult Br vs Fetal Lung and Adult Bone Marrow-Derived Fibroblasts
Flow cytometry analysis revealed that Br cells homogeneously expressed ASO2 (490%), a CD90 antigen epitope specifically exposed on the surface of fibroblasts 18 ( Figure 1 ). In addition, they also strongly expressed the mesenchymal stem/progenitor cell surface antigens CD73, CD105 and CD166 while the expression of STRO-1 was weak. No expression of the endothelial and blood cell antigens CD31, CD34 and CD45 was monitored (not shown). The immunophenotypic profile of Br cells was similar to that of fetal lung IGIG7 and bone marrow BM212 fibroblasts except that STRO-1 was expressed. STRO-1 has been reported to identify human clonogenic bone marrow stromal progenitors able to give rise to cells with the phenotype of fibroblasts, adipocytes, osteocytes and smooth muscle cells. 19 No subpopulations could be distinguished in any cell types on the basis of cell morphology and cellular size and granularity by flow cytometry (Figure 2a) . Moreover, all cells homogeneously expressed CD90 (Figure 2b ), a surface antigen reported to identify different fibroblast subsets with functional diversity. 20, 21 Further evaluation of cystoskeletal and extracellular matrix elements by immunofluorescent staining showed that only a few (o6%) cells stained positively for the myofibroblast marker ASMA in microfilaments (Figure 3a) . Such a low numbers of ASMA ( þ ) cells were similarly detected in ICIG7 and BM212 fibroblasts. Moreover, nearly all Br cells expressed vimentin, nestin but not epithelial panCK in intermediate filaments. Additionally, a homogeneous staining for collagen prolyl 4-hydroxylase and ED-A fibronectin isoform was observed (Figure 3b) . A similar expression pattern was monitored in the two other ICIG7 and BM212 fibroblasts, except that the ED-B fibronectin isoform was abundantly present in fetal lung ICIG7 cells. Table 1 summarizes the results.
Differentiation of Adult Br vs Fetal Lung and Adult Bone Marrow Fibroblasts along Adipogenic, Chondrogenic and Osteogenic Lineages
A marked adipogenesis was induced in the three types of fibroblasts under inducible culture conditions as revealed by oil red O staining (Figure 4) . 
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However, a consistent (15%) percentage of cells were also stained in untreated Br and ICIG7 lungderived controls while absent from untreated bone marrow BM212 controls. It should be noted that in BM212 cultures devoid of basal lipid-containing cells, stimulation by adipogenic medium induced within 1 week changes in cell morphology as well as in the content of lipid droplets that progressively increased in number, coalesced and eventually filled the whole cells by week 3.
Br cells, similarly to fetal lung ICIG7 and adult bone marrow BM212 fibroblasts underwent chondrogenic differentiation when treated with 1 ng/ml of TGF-b1 for 1 week as evidenced by the presence of extracellular cartilage type II collagen immunostaining ( Figure 5 ). This process was not associated with an increase in ASMA expression (data not shown), indicating a chondrocyte-like rather than myofibroblast phenotype induced by TGF-b1 treatment. Untreated control cultures were all negative.
Lastly, all three cell types underwent morphologic changes and formed cell piling up under osteogenic culture conditions ( Figure 6 ). Moreover, abundant amounts of calcium deposits were detected by alizarin red staining consistent with bone formation. Untreated control cultures were all negative.
The mesenchymal differentiation potential of Br cells was consistent with the upregulation in the expression of other lineage-specific genes such as PPARg2, Sox-9 and type II collagen, and osteopontin for adipogenic, chondrogenic and osteogenic activity, respectively, as shown by RT-PCR (Figure 7) .
Discussion
The present study shows that human morphologically fibroblast-like cells isolated from adult Br tissue expressed most of the surface antigens characteristic of MSCs isolated from other adult and fetal tissue sources. 1, 5, 7 The surface antigenic profile of Br cells appeared similar to that of fetal lung and adult bone marrow-derived MSC fibroblastic progenitors except that they weakly expressed STRO-1 antigen whereas the other two did not. STRO-1 is a not yet defined cell surface antigen present in a minor multipotent subpopulation of adult human bone marrow stromal cells growing in long-term culture, the expression of which declining with increasing culture times. 8 As MSC populations appear heterogeneous between species and within cultures, variable expression of some of the mesenchymal markers is commonly reported. It may be due to differences in cell isolation processing, culture conditions and tissue of origin as well.
Besides consensual MSC markers, Br cells predominantly expressed other antigens that characterize ordinary adult tissue fibroblasts, including CD90, vimentin, collagen prolyl 4-hydroxylase, and fibronectin. They also expressed nestin protein in intermediate filaments. Nestin originally described as a predominant neuronal stem/progenitor cell Mesenchymal potential of lung fibroblast F Sabatini et al marker 22 is actually expressed in activated cells from diverse fetal and adult tissues and may relate to a common embryonic cell origin, the neural crest. 23 Regarding cellular heterogeneity, Br cells similarly to fetal lung and adult bone marrow-derived fibroblasts were morphologically homogeneous and only a few myofibroblasts were present. Moreover, we were unable to distinguish cellular subpopulations on the basis of CD90 (Thy-1) expression. CD90 has been reported by Phipps and co-workers to be heterogeneously expressed in fibroblast isolates from various human tissues, including lung, myometrium and orbit. 20, 21, 24 More recently, it successfully helped to discriminate Thy-1( þ ) fibroblasts able to give rise to myofibroblasts from Thy-1(À) cells able to generate lipofibroblasts but not myofibroblasts under inducible conditions. 25 Contrastingly, to these studies, we found that among the homogeneously Thy-1-expressing lung cells, the myofibroblast and lipofibroblast phenotypes were spontaneously present as evidenced by ASMA expression and oil red O staining, respectively.
The presence of lipofibroblasts that contain cytoskeletal proteins characteristics of myofibroblasts, has been previously described in the pulmonary alveolar interstitium. 26 They were shown to produce extracellular matrix components and contribute to surfactant synthesis in type II pneumocytes via their lipid release. However, lipofibroblasts can convert into myofibroblasts under specific TGFb1 stimulation. 27 The conversion process is associated with a gradual loss of adipogenic differentiation-related markers and metabolic changes that in turn affects phospholipid surfactant synthesis by type II pneumocytes. 28 We show that the formation of lipofibroblasts was increased in Br and fetal lung cultures under inducible adipogenic conditions. Most remarkably, Br fibroblasts were also capable of differentiating along the chondrogenic and osteogenic lineages and may be, thus, considered as closely related to MSCs.
It is most likely that resident MSCs in adult tissues are involved in the maintenance and repair of injured tissues. Preliminary studies have indicated that bone marrow-derived MSCs might be applied therapeutically for the correction of disorders from mesenchymal origin as osteogenesis imperfecta. 29 Furthermore, it has been shown that marrow stem cells were able to deliver gene therapy to lung epithelium while maintaining long-term transgene expression. 10 The existence of MSCs in the lung we reported here may offer efficient therapeutical approaches to a variety of lung disorders, through the manipulation of processes involved in airway remodeling that follow acute injury, the correction of acquired or genetically determined mesenchymal cell disorders and, possibly, the delivery of a transgenic protein to other airway structural cells, including Br epithelial cells. 
